The latest report published by IMARC Group, titled “Fluorescent in Situ Hybridization (FISH) Probe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the FISH probe market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The market size reached US$ 816 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,224 Million by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.
Fluorescent in situ hybridization (FISH) probe is a powerful molecular biology technique used to detect and localize specific nucleic acid sequences within cells or tissues. FISH probes are short, single-stranded DNA or RNA sequences that are labelled with fluorescent dyes. These probes are complementary to the target sequence of interest, allowing them to hybridize specifically to the complementary DNA or RNA strands within the sample. The fluorescent label attached to the probe emits a signal when excited by a specific wavelength of light, enabling visualization and precise localization of the target sequence under a fluorescence microscope.
One of the key characteristics of FISH probes is their specificity. They are designed to bind only to the intended target sequence, minimizing background noise and false positives. FISH probes can also be designed to detect multiple targets simultaneously by using different coloured fluorescent labels for each probe. At present, FISH probes are extensively utilized by research organizations and various diagnostic centers.
The increasing incidence of genetic disorders and chromosomal abnormalities represents one of the key factors influencing the market growth of fluorescent in situ hybridization probes for diagnostic purposes. Moreover, the rising focus on personalized medicine, which involves tailoring treatment based on an individual’s genetic profile, is contributing to the market growth of FISH probes.
The ongoing developments in probe design, such as the introduction of novel fluorophores and improvements in labelling techniques, are expanding the capabilities and applications of FISH probes, thereby propelling the market growth. The availability of funding and grants for genetic research projects is supporting the market growth of FISH probes, as researchers are investing in advanced tools and technologies for their studies.
The increasing adoption of molecular diagnostic techniques, including FISH probes, in clinical settings is propelling the market growth. The pharmaceutical industry’s need for tools to identify and validate gene targets for drug discovery and development is contributing to the market growth of FISH probes. FISH probes find applications in agricultural biotechnology for crop improvement, identification of pathogens, and studying gene expression patterns, which is fueling the market growth.
The increasing awareness and acceptance of genetic testing among the general population are creating a significant demand for FISH probes, as they are used in various genetic tests for disease risk assessment and carrier screening. This is influencing the market growth positively. The availability of favourable reimbursement policies for genetic testing procedures, including FISH-based tests, is facilitating market growth by increasing accessibility and affordability.
The growing establishment of biobanks and biorepositories for storing and analysing biological samples is driving the market growth of FISH probes. Besides this, the steadily expanding geriatric population, which is more prone to genetic disorders and diseases, is increasing the need for accurate and reliable diagnostic tools like FISH probes, thereby driving the market growth.
Other factors, such as extensive research in genomics and gene expression analysis, increasing number of collaborations and partnerships among the key players, and growing application of FISH probes in veterinary diagnostics, are creating a positive outlook for the market further across the globe.
The competitive landscape of the fluorescent in situ hybridization (FISH) probe market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abnova Corporation
- Agilent Technologies Inc.
- Biocare Medical LLC
- Biosearch Technologies (LGC Ltd.)
- Creative Biolabs
- F. Hoffmann-La Roche Ltd. (Roche Holding AG)
- Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.)
- Merck KGaA
- Oxford Gene Technology (Sysmex Corporation)
- PerkinElmer Inc.
- ThermoFisher Scientific Inc.
Key Market Segmentation:
The report has segmented the global fluorescent in situ hybridization (FISH) probe market based on type, probe type, technology, application, end-user and region.
Breakup by Type:
Breakup by Probe Type:
- Locus Specific Probes
- Alphoid/Centromeric Repeat Probes
- Whole Chromosome Probes
Breakup by Technology:
- Flow FISH
- Q FISH
Breakup by Application:
- Genetic Diseases
Breakup by End-User:
- Research Organizations
- Diagnostic Centers
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/fluorescent-situ-hybridization-probe-market
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Company Name: IMARC Group
Contact Person: Elena Anderson
Address: 134 N 4th St
Country: United States